- Time of issue:2020-03-12 00:00:00
Our research and development is led by senior scientists who have decades of experience in drug development and entrepreneurship in the United States. They provide us with comprehensive expertise covering small molecules, biologics, and compound design. We have built an integrated research and development platform to support our drug development programs from drug discovery to clinical trials.We conduct our own research to discover and select new compounds as drug candidates in development and manage the outsourced drug development projects, using internal research and development resources to ensure that the process meets our internal quality standards.Through years of effort, we have gained industry-leading expertise in molecular design, PK/PD modeling etc. We continue our research and exploration in new areas of cancer and skin diseases to meet the needs of global patients through existing research and development platforms. We are especially interested in new technologies such as PROTAC (protein degradation targeted chimera).
Through years of hard work, we have accumulated industry-leading expertise in the fields of molecular design and PK / PD modeling. Through existing R & D platforms, especially new technologies such as PROTAC (Protein Degradation Targeting Chimera), we are exploring the pharmaceutical Continued research and exploration in areas of concern such as tumors and skin diseases to meet the needs of patients worldwide.
Scan the QR code to read on your phone